COc1ccc2c(c1)OC[C@H]1[C@H]2N2C(=O)CN(C)C(=O)[C@@]2(C)[C@H]1c1ccccc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?